Takashi Yahata
Isehara, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Inflammatory macrophage-derived plasminogen activator inhibitor-1 exacerbates inflammation through efferocytosis inhibition.
Journal: Cell death discovery
Published: January 21, 2026
Notch interaction with RUNX factors regulates initiation of the T-lineage program.
Journal: The Journal of experimental medicine
Published: May 04, 2025
A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial.
Journal: The British journal of dermatology
Published: April 18, 2024
Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1.
Journal: Frontiers in immunology
Published: January 05, 2024
Mitochondrial Electron Transport Chain Complex II Dysfunction Causes Premature Aging of Hematopoietic Stem Cells.
Journal: Stem cells (Dayton, Ohio)
Published: March 29, 2022
Dll1 Can Function as a Ligand of Notch1 and Notch2 in the Thymic Epithelium.
Journal: Frontiers in immunology
Published: January 11, 2022
IMiDs uniquely synergize with TKIs to upregulate apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells expressing a dominant-negative IKZF1 isoform.
Journal: Cell death discovery
Published: April 02, 2021
Plasminogen activator inhibitor type-1 is a negative regulator of hematopoietic regeneration in the adipocyte-rich bone marrow microenvironment.
Journal: Biochemical and biophysical research communications
Published: February 26, 2021
Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells.
Journal: Cancer cell international
Published: April 17, 2020
Last Updated: 09/26/2026